Literature DB >> 20182717

Letter: The importance of complete pathologic response after neoadjuvant systemic treatment in breast cancer research and practice.

K Kalogerakos.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20182717     DOI: 10.1007/s00268-010-0496-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  12 in total

1.  Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology.

Authors:  Dimitrios H Roukos
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

2.  Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer.

Authors:  Dimitrios H Roukos
Journal:  J Clin Oncol       Date:  2009-02-02       Impact factor: 44.544

3.  Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the "Gordian Knot"?

Authors:  Dimitrios H Roukos; Dimosthenis Ziogas
Journal:  Ann Surg Oncol       Date:  2008-07-09       Impact factor: 5.344

4.  Radiation therapy for breast cancer.

Authors:  Dimitrios H Roukos
Journal:  N Engl J Med       Date:  2009-03-26       Impact factor: 91.245

5.  Isolated tumor cells in breast cancer.

Authors:  Dimitrios H Roukos
Journal:  N Engl J Med       Date:  2009-11-12       Impact factor: 91.245

6.  Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.

Authors:  Dimitrios H Roukos; Andreas Tzakos; George Zografos
Journal:  Expert Rev Anticancer Ther       Date:  2009-10       Impact factor: 4.512

7.  From tumor size and HER2 status to systems oncology for very early breast cancer treatment.

Authors:  Dimitrios H Roukos; Dimosthenis Ziogas
Journal:  Expert Rev Anticancer Ther       Date:  2010-02       Impact factor: 4.512

Review 8.  Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2010-01       Impact factor: 5.225

9.  Residual nodal disease in biopsy proven n1/n2 breast cancer following neoadjuvant systemic therapy.

Authors:  Fatema Al Mushawah; Marcus C Tan; Julie A Margenthaler
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

Review 10.  Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice.

Authors:  Dimosthenis Ziogas; Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-03-26       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.